Vertex Pharmaceuticals Incorporated vs Workday Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $529.62 (market cap $134.25B), while Workday Inc trades at $178.55 (market cap $44.77B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 3× Workday Inc's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.
| VRTX | WDAY | |
|---|---|---|
Market Cap | $134.25B | $44.77B |
Sector | Health | Technology |
52-Week High | $529.65 | $247.69 |
52-Week Low | $376.62 | $112.55 |
Enterprise Value | $128.37B | $44.22B |
Trailing returns across standard periods
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →